Bupropion can show up as amphetamine or methamphetamine on a standard urine drug test. This is a well-documented false positive, not a detection of actual amphetamine use. The FDA’s own labeling for bupropion (sold as Wellbutrin and Zyban, among other brand names) warns that false-positive urine immunoassay screening tests for amphetamines have been reported in patients taking the medication.
Why Bupropion Triggers Amphetamine Results
Standard workplace and clinical drug tests use a method called immunoassay, which relies on antibodies that bind to the shape of a target drug molecule. The problem is that bupropion belongs to a chemical family called synthetic cathinones, sometimes described as “beta-keto amphetamines” because their molecular structure closely resembles amphetamine. The antibodies in the test kit can’t always tell the difference.
Bupropion itself isn’t the only culprit. Your body breaks the drug down into several metabolites, and at least one of them, called threohydrobupropion, appears to be the primary substance responsible for tripping the amphetamine antibodies in screening kits. Another metabolite, erythrohydrobupropion, shares enough structural similarity to contribute as well. Because these metabolites linger in your system, false-positive results can occur even after you’ve stopped taking bupropion.
Which Drug Tests Are Affected
The standard 5-panel and 10-panel urine drug screens used in most workplace testing include an amphetamine category. That’s the one bupropion interferes with. Research has also found that bupropion can trigger false positives for MDMA (ecstasy) on certain test platforms, and at least one study identified interference with LSD detection using a specific assay type called CEDIA.
One clinical study using the Syva EMIT II immunoassay, a widely used screening platform, found that bupropion was the most frequent cause of false-positive amphetamine screens in their patient population. This isn’t a rare fluke. It’s a recognized, recurring problem with this class of test.
How to Clear a False Positive
A positive immunoassay result is always considered preliminary. It needs to be confirmed by a second, more precise test called gas chromatography/mass spectrometry (GC/MS). This confirmatory test can distinguish bupropion and its metabolites from actual amphetamines with certainty. If your initial screen comes back positive and you’re taking bupropion, a GC/MS confirmation will show no amphetamines present.
In regulated workplace testing (Department of Transportation jobs, federal positions), a Medical Review Officer is required to interview you before reporting a positive result. During that interview, you can disclose your bupropion prescription, and the MRO will order confirmatory testing or review existing confirmation results. SAMHSA guidelines specifically list bupropion as a medication that may produce false-positive results for amphetamines.
What You Should Do Before a Drug Test
If you’re taking bupropion and know you’ll be drug tested, disclose it upfront. You can tell the testing facility, the Medical Review Officer, or whoever administers the test that you take a prescription medication known to cause false positives for amphetamines. You don’t need to stop taking your medication.
Bring documentation of your prescription if possible. A pharmacy printout, prescription bottle, or note from your prescriber all work. This speeds up the review process if your initial screen is flagged. Keep in mind that even if you recently stopped bupropion, its metabolites can still trigger a positive result for some time afterward, so disclosure remains relevant.
The confirmatory GC/MS test is definitive. It will clearly show that the substance in your urine is bupropion, not amphetamine. No one should face consequences from a properly confirmed test result while taking a legitimate prescription. The key is making sure the process gets to that confirmation step rather than stopping at the initial screen.